Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. (Q52576558)
Jump to navigation
Jump to search
scientific article published on 19 April 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. |
scientific article published on 19 April 2018 |
Statements
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study (English)
Antonio Cuneo
George Follows
Gian Matteo Rigolin
Alfonso Piciocchi
Alessandra Tedeschi
Angeles Medina Perez
Marta Coscia
Luca Laurenti
Gerardo Musuraca
Lucia Farina
Alfredo Rivas Delgado
Ester Maria Orlandi
Piero Galieni
Francesca Romana Mauro
Carlo Visco
Angela Amendola
Atto Billio
Roberto Marasca
Vittorio Meneghini
Fiorella Ilariucci
Monia Marchetti
Stefano Molica
Francesca Re
Marcos Gonzalez
Francesco Forconi
Stefania Ciolli
Agostino Cortelezzi
Marco Montillo
Lukas Smolej
Anna Schuh
Toby A Eyre
Ben Kennedy
Carol Moreno
Gianluca Gaidano
Robin FoÃ
GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum
1 reference
1 reference
1 reference